KRYS Krystal Biotech, Inc.: institutional ownership and insider trading
450 funds reported holding $12.1B of Krystal Biotech, Inc. in their latest 13F filings; in Q2 2026 funds net bought $723M, with 88 new positions and 34 funds selling out; over the last 12 months insiders bought $0 and sold $105M on the open market; over its last four quarters it reported revenue of $440M and net income of $241M.
KRYS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $119M, net income $54.8M, EPS 1.79
- Quarter ended Mar 31, 2026: revenue $116M, net income $55.9M, EPS 1.83
- Quarter ended Dec 31, 2025: revenue $107M, net income $51.4M, EPS 1.69
- Quarter ended Sep 30, 2025: revenue $97.8M, net income $79.4M, EPS 2.66
Famous investors holding KRYS
- Ray Dalio (Bridgewater Associates): $20.3M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $22.2M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $16.0M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $10.2M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.67M, 0.0% of the portfolio
Largest institutional holders of KRYS
- FMR LLC — $1.64B
- BlackRock, Inc. (BLK) — $1.55B
- Avoro Capital Advisors LLC — $1.07B
- VANGUARD GROUP INC — $685M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $585M
- STATE STREET CORP (STT, STT-PG) — $502M
- VANGUARD CAPITAL MANAGEMENT LLC — $461M
- Soleus Capital Management, L.P. — $349M
- Capital World Investors — $289M
- GEODE CAPITAL MANAGEMENT, LLC — $260M
Recent KRYS insider trades
- Sep 4, 2026: Krishnan Krish S sold 25,000 shares ($8.98M)
- Sep 4, 2026: Krishnan Suma sold 25,000 shares ($8.98M)
- Aug 14, 2026: Rossi Dino A sold 25,000 shares ($8.23M)
- Jun 25, 2026: Thomas John Charles sold 1,000 shares ($347K)
5%+ owners
- Vanguard Portfolio Management: 5.1% (Schedule 13G, filed Apr 29, 2026)
Who owns the most KRYS stock?
The largest institutional holders of Krystal Biotech, Inc. in the latest 13F filings are FMR LLC ($1.64B), BlackRock, Inc. (BLK) ($1.55B), Avoro Capital Advisors LLC ($1.07B).
Are insiders buying or selling KRYS?
Over the last 12 months insiders bought $0 and sold $105M of Krystal Biotech, Inc. stock on the open market (SEC Form 4).
Which famous investors own KRYS?
Ray Dalio, Renaissance Technologies, Ken Griffin, D. E. Shaw, Two Sigma.
What was KRYS's revenue last quarter?
Krystal Biotech, Inc. reported revenue of $119M for the quarter ended June 30, 2026, with net income of $54.8M.
Which ETFs hold KRYS?
161 ETFs and mutual funds hold it among their top 100 positions, including IJR, FBIOX, CSPAX, IWM.